Ifosfamide and irinotecan in solid tumors:: A phase I dose-finding trial

被引：0
|
作者：
Moyano, AJ
Seguí, MA
Abad, T
Urruticoechea, L
López, JLG
Nogué, M
Dominguez, MS
Balcells, M
Dorado, JF
机构：
[1] Hosp Ramon y Cajal, Med Oncol Serv, E-28034 Madrid, Spain
[2] Hosp Parc Tauli, Med Oncol Serv, Sabadell, Spain
[3] Hosp Txagorvitxu, Med Oncol Serv, Vitoria, Spain
[4] Prasfarma & Co, Barcelona, Spain
[5] Cibest, Madrid, Spain
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 7
页数：5
相关论文
共 50 条
  • [1] Phase I dose finding trial of irinotecan (CPT-11) combined with ifosfamide (IFO) in patients with advanced solid tumors
    Garcia-Lopez, JL
    Segui, MA
    Abad, T
    Gimenez-Arnau, JM
    Moyano, A
    Nogue, M
    Dominguez, S
    Xarles, J
    ANNALS OF ONCOLOGY, 1998, 9 : 136 - 136
  • [2] Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors
    Kuppens, IELM
    Dansin, E
    Boot, H
    Feger, C
    Assadourian, S
    Bonneterre, ME
    Beijnen, JH
    Schellens, JHM
    Bonneterre, J
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3774 - 3781
  • [3] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [4] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
  • [5] Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors
    I. E. L. M. Kuppens
    P. O. Witteveen
    M. Schot
    V. M. Schuessler
    A. Daehling
    J. H. Beijnen
    E. E. Voest
    J. H. M. Schellens
    Investigational New Drugs, 2007, 25 : 227 - 235
  • [6] Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors
    Kuppens, I. E. L. M.
    Witteveen, P. O.
    Schot, M.
    Schuessler, V. M.
    Daehling, A.
    Beijnen, J. H.
    Voest, E. E.
    Schellens, J. H. M.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (03) : 227 - 235
  • [7] Phase I dose-finding study of capecitabine (X) with escalating irinotecan (I) and oxaliplatin (O) in patients (pts) with previously treated solid tumors.
    Samanta, E
    Rigatos, SK
    Triantafillis, M
    Kourtis, S
    Koutsourakis, G
    Papanikitas, K
    Konstantinopoulou, A
    Koussoulas, V
    Aravantinos, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 256S - 256S
  • [8] Biweekly vinorelbine and gemcitabine:: a phase I dose-finding study in patients with advanced solid tumors
    Castellano, D
    Hitt, R
    Ciruelos, E
    Cortés-Funes, H
    Colomer, R
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 783 - 787
  • [9] Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors
    Johnston, Donna L.
    Zupanec, Susan
    Nicksy, Darcy
    Morgenstern, Daniel
    Narendran, Aru
    Deyell, Rebecca J.
    Samson, Yvan
    Wu, Bing
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2019, 66 (06)
  • [10] PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Contouriotis, A. M.
    Law, C. N. J.
    Soria, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 157
12345